Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA.
Proc Natl Acad Sci U S A. 2009 Dec 1;106(48):20234-9. doi: 10.1073/pnas.0908713106. Epub 2009 Nov 11.
Induction of effective antibody responses against HIV-1 infection remains an elusive goal for vaccine development. Progress may require in-depth understanding of the molecular mechanisms of neutralization by monoclonal antibodies. We have analyzed the molecular actions of two rare, broadly neutralizing, human monoclonal antibodies, 4E10 and 2F5, which target the transiently exposed epitopes in the membrane proximal external region (MPER) of HIV-1 gp41 envelope during viral entry. Both have long CDR H3 loops with a hydrophobic surface facing away from the peptide epitope. We find that the hydrophobic residues of 4E10 mediate a reversible attachment to the viral membrane and that they are essential for neutralization, but not for interaction with gp41. We propose that these antibodies associate with the viral membrane in a required first step and are thereby poised to capture the transient gp41 fusion intermediate. These results bear directly on strategies for rational design of HIV-1 envelope immunogens.
诱导针对 HIV-1 感染的有效抗体反应仍然是疫苗开发的一个难以实现的目标。进展可能需要深入了解单克隆抗体中和的分子机制。我们分析了两种罕见的、广谱中和的人源单克隆抗体 4E10 和 2F5 的分子作用,它们针对 HIV-1 gp41 包膜在病毒进入过程中短暂暴露的膜近端外部区域(MPER)表位。两者都具有长的 CDR H3 环,其疏水面背离肽表位。我们发现 4E10 的疏水性残基介导与病毒膜的可逆附着,并且对于中和至关重要,但对于与 gp41 的相互作用不是必需的。我们提出这些抗体以一种必需的第一步与病毒膜结合,从而准备捕获短暂的 gp41 融合中间物。这些结果直接影响 HIV-1 包膜免疫原的合理设计策略。